Boulevard raises $80M to energy self-care growth pushed by Botox and GLP-1 surge

Sports News


The sweetness trade has seen an explosion of choices just lately. Clients can now entry therapies far past primary hair and nail care, from wrinkle-smoothing Botox and fillers to everlasting laser hair removing to weight administration by way of GLP-1 drugs.

Driving this wave of trade development is Boulevard, a supplier of scheduling and cost software program for the self-care sector.

The 9-year-old Boulevard simply raised $80 million in Collection D funding, valuing the enterprise at practically $800 million, a significant uptick from the $595 million valuation it garnered three years in the past. The spherical was led by development fairness agency JMI Fairness and included participation from present buyers Index Ventures and VMG Companions.

When Boulevard launched in 2016, the corporate’s co-founders, Matt Danna and Sean Stavropoulos, needed to resolve what appeared like a easy drawback: permitting individuals to e book hairstyling visits on-line.

The duo couldn’t perceive why salons nonetheless made purchasers name to make appointments. What they found was that salons have been deliberately proof against on-line scheduling: They have been attempting to optimize stylists’ time. 

So, Boulevard constructed a machine learning-based reserving system that considers varied constraints, reminiscent of purchasers’ distinctive service wants and punctuality historical past.

The corporate initially offered their precision-scheduling software program to hair salons, increasing to barbershops, spas, and nail salons.

Techcrunch occasion

San Francisco
|
October 27-29, 2025

Boulevard’s income soared over 500% within the final three years, partly pushed by a burgeoning new consumer phase: medspas. These companies, that are a hybrid between conventional day spas and medical clinics, present nonsurgical, minimally invasive procedures starting from microneedling and Botox to prescribing GLP-1 drugs like Ozempic for weight reduction.

Danna, who serves as Boulevard’s CEO, mentioned he was first stunned that medspa house owners have been concerned about utilizing the corporate’s software program as a substitute of digital medical data methods (EMRs). He found that EMRs are higher suited to purchasers billing insurance coverage, whereas medspas predominantly run on a cash-pay mannequin.

Adapting Boulevard’s software program to serve medspas was fairly easy, Danna mentioned. The corporate grew to become HIPAA compliant and built-in medspa-specific options, together with visible charts for exact Botox and filler injection mapping.

Three years after introducing these options, Boulevard estimates that it’s powering roughly 15% of all medspas within the U.S.

“I’m actually impressed by how magnificence and medical providers strains are blurring,” Danna mentioned. “We now have hair salons that supply medspa providers.”

Through the years, Boulevard expanded its choices to incorporate a web based cost system, a enterprise providing that the corporate unexpectedly stumbled upon. “We ended up studying that if you happen to make it simple to e book on-line, it’s simple to not present up for an appointment,” Danna mentioned. “So, we began capturing bank cards to carry appointments, and that solved the issue of no-shows.”

Although Boulevard initially had no intention of charging these bank cards, prospects requested the corporate use the info for transactions. Boulevard now estimates it can course of roughly $5 billion in funds this 12 months.

In fact, Boulevard has loads of competitors, together with Zenoti, which was final valued at $1 billion in 2020, Fresha, Booksy, and plenty of others.



Source link

- Advertisement -
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -
Trending News

25 Goal Skincare Merchandise To Add To Your Routine

Promising evaluations: "I’ve began reviewing merchandise as a result of I do know that studying evaluations...
- Advertisement -

More Articles Like This

- Advertisement -